Consider opportunities to partner with us in translating research into tangible commercial outcomes.

In collaboration with commercial partners we develop its intellectual property (IP) and over many years have developed a number of applications that are now in use around the world.

Our team supports our scientists in sourcing investment in (and protecting) their IP that allows their work to progress to the next level.

For public health researchers, the support offered by the team might result in diversified funding sources and/or international collaborators that extend the reach of their projects/studies.

> NEW OPPORTUNITIES:

Burnet Vaccine Initiative

Burnet Diagnostic Initiative

Projects

• ALT point-of-care diagnostic to detect liver disease
  Nanjing BioPoint is developing a new diagnostic for detecting liver disease.
• Building a collaborative research agenda with members of ACABS
  Supporting collaboration between Australian and Chinese scientists in the field of biomedical research.
• EVE-M
  Transforming Women's Sexual and Reproductive Health